Gene · 407033
Papers2,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated Analysis of lncRNA-miRNA-mRNA Regulatory Network in Rapamycin-Induced Cardioprotection against Ischemia/Reperfusion Injury in Diabetic Rabbits. | Cells | 2023 | 38132140 | PubTator, text mining | PubMed |
| Exosomes and their derivatives as biomarkers and therapeutic delivery agents for cardiovascular diseases: Situations and challenges. | J Transl Int Med | 2023 | 38130647 | PubTator, text mining | PubMed |
| New understandings of the genetic regulatory relationship between non-coding RNAs and m6A modification. | Front Genet | 2023 | 38125749 | PubTator, text mining | PubMed |
| METTL3/YTHDC1-mediated upregulation of LINC00294 promotes hepatocellular carcinoma progression. | Heliyon | 2023 | 38125436 | PubTator, text mining | PubMed |
| Construction and analysis of pseudogene-related ceRNA network in breast cancer. | Sci Rep | 2023 | 38072995 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Biomarkers of Environmental Exposure to Polycyclic Aromatic Hydrocarbons and Their Link with Inflammation and Lung Cancer. | Int J Mol Sci | 2023 | 38069307 | PubTator, text mining | PubMed |
| The Early Diagnosis of Lung Cancer: Critical Gaps in the Discovery of Biomarkers. | J Clin Med | 2023 | 38068296 | PubTator, text mining | PubMed |
| Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases. | Behav Neurol | 2023 | 38058356 | PubTator, text mining | PubMed |
| Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81). | Diabetes Metab J | 2023 | 38043783 | PubTator, text mining | PubMed |
| Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers. | Front Pediatr | 2023 | 38027263 | PubTator, text mining | PubMed |
| The Clinical Significance of MicroRNAs in Colorectal Cancer Signaling Pathways: A Review. | Glob Med Genet | 2023 | 38025193 | PubTator, text mining | PubMed |
| Muscle miRNAs are influenced by sex at baseline and in response to exercise. | BMC Biol | 2023 | 38012706 | PubTator, text mining | PubMed |
| Knockdown of Simulated-Solar-Radiation-Sensitive miR-205-5p Does Not Induce Progression of Cutaneous Squamous Cell Carcinoma In Vitro. | Int J Mol Sci | 2023 | 38003618 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Human Cancer and Other Diseases: Overview of the Diagnostic Potential. | Int J Mol Sci | 2023 | 38003403 | PubTator, text mining | PubMed |
| MicroRNAs: Midfielders of Cardiac Health, Disease and Treatment. | Int J Mol Sci | 2023 | 38003397 | PubTator, text mining | PubMed |
| Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 38003232 | PubTator, text mining | PubMed |
| Circular RNAs: A New Approach to Multiple Sclerosis. | Biomedicines | 2023 | 38001884 | PubTator, text mining | PubMed |
| Role of Endometrial Extracellular Vesicles in Mediating Cell-to-Cell Communication in the Uterus: A Review. | Cells | 2023 | 37998319 | PubTator, text mining | PubMed |
| Identifying the driver miRNAs with somatic copy number alterations driving dysregulated ceRNA networks in cancers. | Biol Direct | 2023 | 37993951 | PubTator, text mining | PubMed |
| Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis. | Gut Microbes | 2023 | 37979154 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407033/papers?page=5